RedHill Biopharma Ltd. (RDHL)
NASDAQ: RDHL · Real-Time Price · USD
1.330
0.00 (0.00%)
Aug 13, 2025, 12:01 PM - Market open
Paramount Global Employees
RedHill Biopharma had 35 employees as of December 31, 2024. The number of employees decreased by 18 or -33.96% compared to the previous year.
Employees
35
Change (1Y)
-18
Growth (1Y)
-33.96%
Revenue / Employee
$229,800
Profits / Employee
-$236,229
Market Cap
3.05M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 35 | -18 | -33.96% |
Dec 31, 2023 | 53 | -60 | -53.10% |
Dec 31, 2022 | 113 | -88 | -43.78% |
Dec 31, 2021 | 201 | 19 | 10.44% |
Dec 31, 2020 | 182 | 27 | 17.42% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
RDHL News
- 23 days ago - RedHill Receives Positive FDA Feedback on Pathway to Approval of Groundbreaking RHB-204 for Crohn's Disease - PRNewsWire
- 6 weeks ago - RedHill Biopharma Announces Recruitment Initiated into Expanded Phase 2 Opaganib/Darolutamide Combination Study in Advanced Prostate Cancer - PRNewsWire
- 3 months ago - RedHill Biopharma Secures Kukbo Asset Freeze Following RedHill's $8.25 Million Plus Legal Fees New York Supreme Court Summary Judgment Win - PRNewsWire
- 3 months ago - RedHill-Supported Medscape H. Pylori Educational Program to Launch at Major Gastroenterology Congress - PRNewsWire
- 3 months ago - RedHill Biopharma Secures Allowance of Key Chinese Patent Application for Proprietary COVID-19 Treatment, RHB-107 - PRNewsWire
- 4 months ago - RedHill Biopharma Receives Nasdaq Notification Regarding Minimum Stockholders' Equity Deficiency - PRNewsWire
- 4 months ago - RedHill Biopharma's Positive Opaganib Weight Loss & Diabetes Data Published: Signals Potential $100B Market Disruption - PRNewsWire
- 4 months ago - RedHill Biopharma Announces Full-Year 2024 Financial Results and Operational Highlights - PRNewsWire